158. The following provisions of Part 5 (marketing authorisations) apply to an Article 126a authorisation as they apply to a marketing authorisation—
(a)regulation 62 (classification of marketing authorisation);
(b)regulation 63 (frequency of periodic safety update reports);
(c)regulation 68 (revocation etc of marketing authorisation) and Schedule 11 (advice and representations in connection with revocations etc) so far as relating to that regulation;
(d)regulation 69 (suspension of use etc of medicinal product);
(e)regulation 71 (withdrawal of medicinal products from the market);
(f)regulation 72 (sale etc of suspended medicinal product);
(g)regulation 80 (urgent safety restrictions); and
(h)regulations 98 (general offence of breach of provision of this Part), 99 (penalties) and 101(1) and (2) (defences), so far as relating to the regulations mentioned in sub-paragraphs (a) and (e) to (f).